Privia Health Group (NASDAQ:PRVA) was upgraded by analysts at Royal Bank Of Canada to a "moderate buy" rating.
Privia Health Group (NASDAQ:PRVA) is now covered by analysts at Royal Bank Of Canada. They set an "outperform" rating and a $31.00 price target on the stock.
Privia Health Group (NASDAQ:PRVA) was given a new $31.00 price target on by analysts at Wolfe Research.
Privia Health Group (NASDAQ:PRVA) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Privia Health Group (NASDAQ:PRVA) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.